This is a preview of subscription content, log in via an institution to check access.
Notes
compound annual growth rate
Reference
Prime Therapeutics. Specialty drug costs account for more than 50 percent of the total cost of care for rheumatoid arthritis and hepatitis C patients. Media Release : 2 Apr 2013. Available from: URL: http://www.primetherapeutics.com
Rights and permissions
About this article
Cite this article
High cost burden of RA and hep C speciality drugs. PharmacoEcon Outcomes News 676, 8 (2013). https://doi.org/10.1007/s40274-013-0324-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0324-7